Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Journal of Reproduction and Fertility|November 1, 1993
Sex differences in plasma corticosterone in mouse fetuses are mediated by differential placental transport from the mother and eliminated by maternal adrenalectomy or stressM M Montano, M H Wang, F S vom Saal
Biology of Reproduction|November 1, 1995
Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female ratsM M Montano, W V Welshons, F S vom Saal
Oncogene|May 24, 2011
The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sitesN Krishnamurthy, C R Ngam, A J Berdis, et al.
The Journal of Biological Chemistry|February 11, 1994
Phosphorylation of the human estrogen receptor. Identification of hormone-regulated sites and examination of their influence on transcriptional activityP Le Goff, M M Montano, D J Schodin, et al.
Physiology & Behavior|August 1, 1991
Serum corticosterone in fetal mice: sex differences, circadian changes, and effect of maternal stressM M Montano, M H Wang, M D Even, et al.
Breast Cancer Research and Treatment|May 1, 1997
William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancerB S Katzenellenbogen, M M Montano, K Ekena, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1996
Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogensM M Montano, K Ekena, K D Krueger, et al.
Oncogene|March 23, 2011
HEXIM1 is a critical determinant of the response to tamoxifenW Ketchart, N Ogba, A Kresak, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 9, 1999
An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogensM M Montano, K Ekena, R Delage-Mourroux, et al.
Oncogene|July 30, 2008
hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifenS P Sripathy, L J Chaplin, N W Gaikwad, et al.
Pageof 3